富士製薬工業の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/07/25 | 1,400 | 1,400 | 1,379 | 1,382 | -24 | -1.7% | 132,300 |
| 2024/07/24 | 1,427 | 1,433 | 1,406 | 1,406 | -28 | -2% | 84,400 |
| 2024/07/23 | 1,428 | 1,436 | 1,420 | 1,434 | +19 | +1.3% | 71,600 |
| 2024/07/22 | 1,458 | 1,460 | 1,414 | 1,415 | -51 | -3.5% | 221,800 |
| 2024/07/19 | 1,458 | 1,484 | 1,418 | 1,466 | -85 | -5.5% | 925,000 |
| 2024/07/18 | 1,555 | 1,570 | 1,551 | 1,551 | -13 | -0.8% | 56,200 |
| 2024/07/17 | 1,554 | 1,583 | 1,549 | 1,564 | +24 | +1.6% | 91,400 |
| 2024/07/16 | 1,550 | 1,565 | 1,540 | 1,540 | +8 | +0.5% | 78,600 |
| 2024/07/12 | 1,526 | 1,547 | 1,520 | 1,532 | -1 | -0.1% | 59,000 |
| 2024/07/11 | 1,523 | 1,537 | 1,511 | 1,533 | +35 | +2.3% | 69,300 |
| 2024/07/10 | 1,500 | 1,505 | 1,489 | 1,498 | -6 | -0.4% | 51,400 |
| 2024/07/09 | 1,480 | 1,521 | 1,478 | 1,504 | +14 | +0.9% | 103,900 |
| 2024/07/08 | 1,510 | 1,528 | 1,486 | 1,490 | -17 | -1.1% | 66,500 |
| 2024/07/05 | 1,475 | 1,510 | 1,475 | 1,507 | +32 | +2.2% | 104,000 |
| 2024/07/04 | 1,479 | 1,480 | 1,461 | 1,475 | -4 | -0.3% | 138,500 |
| 2024/07/03 | 1,469 | 1,481 | 1,469 | 1,479 | +10 | +0.7% | 87,000 |
| 2024/07/02 | 1,478 | 1,490 | 1,464 | 1,469 | -9 | -0.6% | 122,400 |
| 2024/07/01 | 1,502 | 1,511 | 1,478 | 1,478 | -18 | -1.2% | 94,200 |
| 2024/06/28 | 1,500 | 1,504 | 1,482 | 1,496 | +7 | +0.5% | 101,300 |
| 2024/06/27 | 1,454 | 1,497 | 1,454 | 1,489 | +45 | +3.1% | 123,900 |
| 2024/06/26 | 1,438 | 1,453 | 1,431 | 1,444 | +7 | +0.5% | 109,500 |
| 2024/06/25 | 1,435 | 1,452 | 1,434 | 1,437 | -7 | -0.5% | 139,300 |
| 2024/06/24 | 1,448 | 1,450 | 1,435 | 1,444 | +3 | +0.2% | 91,300 |
| 2024/06/21 | 1,483 | 1,494 | 1,428 | 1,441 | -38 | -2.6% | 118,100 |
| 2024/06/20 | 1,499 | 1,499 | 1,460 | 1,479 | -18 | -1.2% | 85,800 |
| 2024/06/19 | 1,476 | 1,500 | 1,476 | 1,497 | +25 | +1.7% | 73,500 |
| 2024/06/18 | 1,472 | 1,485 | 1,465 | 1,472 | +9 | +0.6% | 62,300 |
| 2024/06/17 | 1,427 | 1,471 | 1,422 | 1,463 | +13 | +0.9% | 122,700 |
| 2024/06/14 | 1,401 | 1,458 | 1,401 | 1,450 | +33 | +2.3% | 111,800 |
| 2024/06/13 | 1,434 | 1,434 | 1,413 | 1,417 | -17 | -1.2% | 76,000 |
| 2024/06/12 | 1,445 | 1,453 | 1,432 | 1,434 | -11 | -0.8% | 65,500 |
| 2024/06/11 | 1,490 | 1,490 | 1,445 | 1,445 | -43 | -2.9% | 69,500 |
| 2024/06/10 | 1,458 | 1,494 | 1,458 | 1,488 | +31 | +2.1% | 67,100 |
| 2024/06/07 | 1,487 | 1,487 | 1,456 | 1,457 | -30 | -2% | 73,800 |
| 2024/06/06 | 1,489 | 1,503 | 1,470 | 1,487 | +6 | +0.4% | 71,800 |
| 2024/06/05 | 1,493 | 1,494 | 1,469 | 1,481 | -13 | -0.9% | 61,000 |
| 2024/06/04 | 1,500 | 1,516 | 1,491 | 1,494 | -16 | -1.1% | 43,500 |
| 2024/06/03 | 1,486 | 1,514 | 1,486 | 1,510 | +25 | +1.7% | 51,600 |
| 2024/05/31 | 1,458 | 1,491 | 1,458 | 1,485 | +27 | +1.9% | 88,100 |
| 2024/05/30 | 1,442 | 1,458 | 1,433 | 1,458 | +1 | +0.1% | 57,000 |
| 2024/05/29 | 1,470 | 1,477 | 1,457 | 1,457 | -17 | -1.2% | 42,100 |
| 2024/05/28 | 1,500 | 1,500 | 1,464 | 1,474 | -26 | -1.7% | 93,900 |
| 2024/05/27 | 1,482 | 1,514 | 1,477 | 1,500 | +23 | +1.6% | 57,100 |
| 2024/05/24 | 1,457 | 1,495 | 1,454 | 1,477 | -6 | -0.4% | 129,400 |
| 2024/05/23 | 1,450 | 1,492 | 1,430 | 1,483 | +41 | +2.8% | 159,100 |
| 2024/05/22 | 1,505 | 1,506 | 1,437 | 1,442 | -76 | -5% | 304,100 |
| 2024/05/21 | 1,516 | 1,539 | 1,515 | 1,518 | ±0 | ±0% | 59,600 |
| 2024/05/20 | 1,513 | 1,545 | 1,510 | 1,518 | -5 | -0.3% | 93,300 |
| 2024/05/17 | 1,517 | 1,534 | 1,505 | 1,523 | +13 | +0.9% | 40,500 |
| 2024/05/16 | 1,530 | 1,530 | 1,501 | 1,510 | -19 | -1.2% | 48,600 |
201～
250
件表示中 / 6958件
類似銘柄と比較する
現在ご覧いただいている「富士製薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 富士製薬 | 128,500円 | +15.7% | +5.3% | 3.54% | 9.29倍 | 0.69倍 |
|
女性医療、急性期医療の２領域に強い後発薬メーカー。注射剤が主体。新薬・バイオ後続品も |
| 生化学 | 63,900円 | -9.6% | -30.2% | 4.69% | 25.83倍 | 0.48倍 |
|
複合糖質で独自性。開発は関節疾患関連に特化。２種のヒアルロン酸製剤は科研と参天が販売 |
| ヘリオス | 32,900円 | +150.0% | - | 0.00% | - | 16.18倍 |
|
ｉＰＳ細胞、体性幹細胞を活用する再生医薬品バイオベンチャー。住友ファーマと共同開発も |
| ダイト | 205,700円 | +4.5% | -33.7% | 3.40% | 20.56倍 | 0.59倍 |
|
医薬品の原薬製造販売や、製剤の製造受託が主力。ジェネリック（後発医薬品）メーカー向け強い |
| ミズホメディ | 150,100円 | +1.2% | -13.9% | 5.66% | 8.85倍 | 1.65倍 |
|
体外検査薬専業、感染症抗体、遺伝子検査機器、試薬開発。新型コロナで急成長、妊娠検査薬も |
市場注目の銘柄
チャート関連のコラム
